These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35872774)

  • 1. Outcome of Using Intraventricular Plus Intravenous Polymyxin B in Post-neurosurgical Patients With Multi/Extensively Drug-Resistant Gram-Negative Bacteria-Induced Intracranial Infection.
    Li H; Yu W; Wang G; Cai H
    Front Med (Lausanne); 2022; 9():913364. PubMed ID: 35872774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study.
    Hu Y; Li D; Zhang G; Dai Y; Chen M; Jiang H; Cui W
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):875-884. PubMed ID: 38443737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Carbapenem-Resistant Multidrug-Resistant Gram-Negative Bacilli with Intracerebroventricular Injection of Polymyxin B: A Retrospective Study.
    Liu D; Niu J; Chen G; Xu L
    Infect Drug Resist; 2022; 15():7653-7666. PubMed ID: 36579127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinical Study on the Use of Intraventricular Polymyxin B Supplemented by Continuous External Ventricular Drainage in the Treatment of Drug-Resistant Gram-Negative Bacilli Intracranial Infection.
    Chen H; Guo X; Xie D; Dong X; Niu J; Chen G
    Infect Drug Resist; 2020; 13():2963-2970. PubMed ID: 32904679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant Gram-negative post-neurosurgical meningitis and the role of intraventricular colistin: a case series.
    Iaria C; Giammalva GR; Spicola D; Fimognari AM; Imburgia C; Di Lorenzo F; Ficalora A; Sanfilippo A; Mazzarese V; Scafidi A; Cimó F; Capodicasa A; Marsala GL; Saporito A; Di Bernardo F; Iacopino D; Fiorenza V
    Infez Med; 2021 Mar; 29(1):130-137. PubMed ID: 33664183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of intraventricular polymyxin B plus continuous ventricular drainage for the treatment of intracranial infection caused by drug-resistant Acinetobacter baumannii.
    Chen L; Li X; Li D; Dong X; Chen H
    Ann Palliat Med; 2022 Feb; 11(2):490-497. PubMed ID: 35249326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraventricular Plus Systemic Antibiotic Therapy for Treating Polymyxin-Resistant
    Wang H; Zhou Q; Huang K; Yang X; Wen L
    Open Forum Infect Dis; 2022 Apr; 9(4):ofac084. PubMed ID: 35355891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of combination therapy with intrathecal or intraventricular administration of polymyxin B for hospital-acquired central nervous system infections caused by carbapenem-resistant Acinetobacter baumannii: a retrospective study.
    Xu C; Zeng F; Xu Q; Yang Y; Zhang Y; Shi C
    Int J Antimicrob Agents; 2024 Sep; ():107334. PubMed ID: 39312980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime-Avibactam for the Treatment of Central Nervous System Infection Caused by Pan Drug-Resistant Carbapenem-Resistant Klebsiella Pneumoniae: A Case Report.
    Zhang Y; Hou G; Zhang L; Li S
    Infect Drug Resist; 2024; 17():3501-3506. PubMed ID: 39157745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical intracranial infection due to multidrug-resistant and extensively drug-resistant Gram-negative bacteria: A systematic review and meta-analysis.
    Hu Y; He W; Yao D; Dai H
    Int J Antimicrob Agents; 2019 Nov; 54(5):556-561. PubMed ID: 31398478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Central Nervous System Infection Caused by Multidrug-Resistant
    Yang X; Guo C; Wu G; Zhao K; Xiang D; Xu D; Liu D; He Y
    Infect Drug Resist; 2023; 16():6029-6038. PubMed ID: 37719653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Presentations and Outcomes of Post-Operative Central Nervous System Infection Caused by Multi-Drug-Resistant/Extensively Drug-Resistant
    Liang W; Yuan-Run Z; Min Y
    Surg Infect (Larchmt); 2019 Sep; 20(6):460-464. PubMed ID: 30942663
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant
    Du N; Mao EQ; Yang ZT; Qu HP; Qian X; Shi Y; Bian XL; He J; Chen EZ
    Infect Drug Resist; 2022; 15():7219-7226. PubMed ID: 36533251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of sepsis with extensively drug resistant Gram-negative bacteria in intensive care unit treated with polymyxin B-based combination therapy].
    Zhao S; Yan L; Wang C; Peng M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):150-154. PubMed ID: 32274997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR
    Xing H; Cheng C; Zhang Y; Cai Y; Wang X; Deng D; Xu L; Xu M; Chen J
    Front Pediatr; 2021; 9():564991. PubMed ID: 34386463
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic drug monitoring of polymyxin B cerebrospinal fluid concentrations in patients with carbapenem-resistant Gram-negative bacteria-induced central nervous system infection.
    Wang P; Liu S; He X; Miao W; Sun T; Yang J
    J Antimicrob Chemother; 2024 Aug; 79(8):1969-1973. PubMed ID: 38870067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymyxin for the treatment of intracranial infections of extensively drug-resistant bacteria in children after neurosurgical operation.
    Ye J; Tan LH; Shen ZP; Yu YS; Lai DM; Fan J; Shu Q
    World J Pediatr; 2020 Oct; 16(5):528-532. PubMed ID: 32193830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential intraventricular injection of tigecycline and polymyxin B in the treatment of intracranial Acinetobacter baumannii infection after trauma: a case report and review of the literature.
    Zhong L; Shi XZ; Su L; Liu ZF
    Mil Med Res; 2020 May; 7(1):23. PubMed ID: 32389124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.